Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/13/20 → 12/31/25 |
Funding
- Lilly USA LLC: $477,599.00
Synergy: A Randomized Double-Blind Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)
- Chaudhuri, Ajay (PI)
- Talal, Andrew (PI)
Project: Research